Minocycline is a promising candidate as a combination therapy with caspofungin for drug-resistant Candida
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1452497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Kazuhiro Itoh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, NHO Awara National Hospital, Awara, Japan. Hauptthemen laut MEDLINE: Caspofungin, Antifungal Agents, Minocycline, Drug Therapy, Combination. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, NHO Awara National Hospital, Awara, Japan.
- Division of Infection Control and Prevention, University of Fukui Hospital, Fukui, Japan.
Zitieren
APA
Itoh, K., Tsutani, H., Mitsuke, Y., & Iwasaki, H. (2024). Minocycline is a promising candidate as a combination therapy with caspofungin for drug-resistant Candida. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1452497
Vancouver
Itoh K, Tsutani H, Mitsuke Y, Iwasaki H. Minocycline is a promising candidate as a combination therapy with caspofungin for drug-resistant Candida. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1452497
BibTeX
@article{Itoh2024,
author = {Itoh, Kazuhiro and Tsutani, Hiroshi and Mitsuke, Yasuhiko and Iwasaki, Hiromichi},
title = {Minocycline is a promising candidate as a combination therapy with caspofungin for drug-resistant Candida},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1452497}
}
EUVIMED